36 results
424B3
HSCS
Heart Test Laboratories Inc.
18 Mar 24
Prospectus supplement
6:06am
and support further research and development (“R&D”).
We believe that there is currently no low-cost, front-line, medical device that is effective … further R&D.
To date we have had no discussions with the FDA regarding the Cloud Platform or Mount Sinai licensed AI-ECG algorithms although we
8-K
EX-99.1
HSCS
Heart Test Laboratories Inc.
14 Mar 24
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
4:15pm
cardiovascular indications. We expect this will save years of R&D and millions of dollars in data acquisition and algorithm development costs as well as providing
424B5
5x706 jfdeb20h
17 Nov 23
Prospectus supplement for primary offering
4:51pm
424B5
cht8emu il
9 Nov 23
Prospectus supplement for primary offering
7:50pm
424B5
xz29m6al0spv9m4p6
4 Oct 23
Prospectus supplement for primary offering
5:00pm
S-3
aflsfruz8 ijxa9c
18 Sep 23
Shelf registration
6:09am
DRS
8p6hs76bqkh
10 May 23
Draft registration statement
12:00am
424B3
uycpn14p duy
11 Apr 23
Prospectus supplement
9:02am
424B3
apvk6
16 Dec 22
Prospectus supplement
11:50am
424B3
m6pcto8coqz9tjax
11 Oct 22
Prospectus supplement
9:31am